H. Romero

Different detection rates of HER-2/NEU overexpression in ovarian carcinoma using two different commercially available detection kits.

J. Schneider, J. Schneider, H. Romero, 1995, European journal of cancer.

S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers

J. Burgos, F. Rodríguez-Escudero, J. Bilbao, 2005, Breast Cancer Research and Treatment.

nm23 expression in advanced and borderline ovarian carcinoma.

J. Schneider, F. Rodríguez-Escudero, M. Centeno, 1996, Anticancer Research.

Cross-reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies PA10F and C6.

J. Schneider, E. Jiménez, H. Romero, 1998, British Journal of Cancer.

Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens

J. Schneider, G. Barrenetxea, M. Centeno, 1996, Cancer Chemotherapy and Pharmacology.

Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients.

J. Schneider, D. Marx, H. Meden, 1999, Anticancer research.

Correlation of P-glycoprotein overexpression and cellular prognostic factors in formalin-fixed, paraffin-embedded tumor samples from breast cancer patients.

J. Schneider, H. Romero, 1995, Anticancer research.